Transcranial magnetic stimulation (TMS) has become one of the most effective treatments available for instances of Depression that have not responded to medication. As the technology has advanced, so have
How Esketamine as a Glutamate Depression Treatment is Changing the Landscape of MDD
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, affecting more than 280 million people. While traditional antidepressants have helped millions, about one-third of people with
Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults
For many older adults, Depression is more than just sadness. It can be persistent, debilitating, and resistant to standard treatment. In fact, a significant number of adults over the age
Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs
GLP-1 medications like Ozempic and Wegovy show promise in treating Depression, addiction, and cognitive issues. But what are GLP-1 drugs exactly, how do they work, what promise and results have
When Antidepressants Stop Working: An Update on “Poop Out”
Antidepressants have brought relief to millions of people struggling with major depressive disorder (MDD). They can restore energy, stabilize mood, and allow patients to reclaim parts of their lives that
Does Ketamine Improve Quality of Life for People with Depression?
When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in
Depression and Cardiovascular Disease
Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading
Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown
BDNF: A Key Transducer of the Effects of Antidepressants, Ketamine and TMS
What is BDNF Protein? BDNF stands for brain-derived neurotrophic factor and is a protein that is widely expressed in the central nervous system (CNS) and acts as a growth factor